Families seeking gender-affirming care for their children are likely to face a fractured legal and health-care system in 2024 as Democratic-led states attempt to enact protections on treatments for gender dysphoria, policy analysts say.
This year saw a surge in states banning puberty-blocking drugs, hormone therapy, and other care for transgender minors, with 22 states now prohibiting at least one form of gender-affirming care, according to the Movement Advancement Project.
The restrictions have prompted families to travel to other states to access care, similar to the movement of patients seeking abortion care amid state bans on the procedure. California, Massachusetts, ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.